NDC Package 70700-307-85 Feirza 1/20

Norethindrone Acetate And Ethinyl Estradiol Tablets Usp,1 Mg/0.02 Mg And Ferrous Fumarate - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70700-307-85
Package Description:
3 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH (70700-307-84) / 1 KIT in 1 BLISTER PACK
Product Code:
Proprietary Name:
Feirza 1/20
Non-Proprietary Name:
Norethindrone Acetate And Ethinyl Estradiol Tablets Usp, 1 Mg/0.02 Mg And Ferrous Fumarate Tablets, 75 Mg
Usage Information:
Feirza 1/20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.TABLE I: LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHODAdapted from RA Hatcher et al, Reference 7.% Of Women Experiencing an Unintended Pregnancyin the First Year of Continuous UseMethodLowest ExpectedThe authors’ best guess of the percentage of women expected to experience an accidental pregnancy among couples who initiate a method (not necessarily for the first time) and who use it consistently and correctly during the first year if they do not stop for any other reason.TypicalThis term represents “typical” couples who initiate use of a method (not necessarily for the first time), who experience an accidental pregnancy during the first year if they do not stop use for any other reason.(No contraception) (85)(85)Oral contraceptives 3      combined 0.1N/A N/A - Data not available.      progestin only 0.5N/A Diaphragm with spermicidal cream or jelly 620Spermicides alone (foam, creams, gels, vaginal suppositories,and vaginal film) 626Vaginal Sponge      nulliparous 920      parous2040Implant 0.050.05Injection: depot medroxyprogesterone acetate 0.30.3IUD      progesterone T 1.52      copper T 380A 0.60.8      LNg 20 0.10.1Condom without spermicides      female 521      male 314Cervical Cap with spermicidal cream or jelly      nulliparous 920      parous 2640Periodic abstinence (all methods) 1 to 925Withdrawal 419Female sterilization 0.50.5Male sterilization 0.100.15 
11-Digit NDC Billing Format:
70700030785
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
3 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1358762 - norethindrone acetate 1 MG / ethinyl estradiol 0.02 MG Oral Tablet
  • RxCUI: 1358762 - ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet
  • RxCUI: 1358762 - ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Oral Tablet
  • RxCUI: 1358763 - {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack
  • RxCUI: 1358763 - Eth-estra-Noreth Ac 0.02-1 MG (21) Oral Tablet / Ferr fum 75 MG (7) Oral Tablet 28 Day Pack
Product Type:
Human Prescription Drug
Labeler Name:
Xiromed Llc
Dosage Form:
Kit - A packaged collection of related material.
Sample Package:
No
FDA Application Number:
ANDA202772
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
01-29-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70700-307-85?

The NDC Packaged Code 70700-307-85 is assigned to a package of 3 pouch in 1 carton / 1 blister pack in 1 pouch (70700-307-84) / 1 kit in 1 blister pack of Feirza 1/20, a human prescription drug labeled by Xiromed Llc. The product's dosage form is kit and is administered via form.

Is NDC 70700-307 included in the NDC Directory?

Yes, Feirza 1/20 with product code 70700-307 is active and included in the NDC Directory. The product was first marketed by Xiromed Llc on January 29, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70700-307-85?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 3.

What is the 11-digit format for NDC 70700-307-85?

The 11-digit format is 70700030785. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270700-307-855-4-270700-0307-85